Hypothesis Testing Problem
• Interest will focus on testing for treatment difference
• Let Z 1 , . . . , Z N be iid p (z, δ) , where δ denotes treatment difference 
Fixed Sample Test
• For fixed sample size N , the Neyman-Pearson theorem states that among all level α tests, the test which maximizes power against the alternative δ > 0 is given by the rejection region
where C is chosen so that P 0 (R opt ) = α
• In our example, this is equivalent to rejecting H 0 when
where δ A denotes the clinically important difference that we wish to detect with power 1 − β
Drawbacks
• Doesn't allow for the possibility of stopping early to reject or accept the null hypothesis
• Need to specify clinically important alternative
Inefficiency of Adaptive Designs

Group-Sequential Tests
• Interim analyses are conducted after n 1 < . . . < n K = N observations with the possibility of stopping the trial at each analysis
• The boundaries C jL , C jU , j = 1, . . . , K and the maximum sample size N are chosen so that the test has specified level α and power 1 − β to detect the clinically important difference δ A
• Traditional designs for clinical trials dictate that we specify the clinically important treatment difference that needs to be detected with specified power using a test at a specified level of significance
• The difficulty is that often we don't have a good idea on what constitutes a clinically important difference
• Adaptive designs, which estimate the treatment difference using the observed data and adaptively change the design according to the estimated treatment difference, have a great deal of appeal
Example of an Adaptive Design
• Choose initial alternative δ A = .466
• We adapt a two-stage design (n 1 = 25, n 2 = 50)
• A standard two stage group-sequential test would be 
to correspond roughly to the sample size needed to detect the differenceδ with 90% power at the .025 level of significance
• In our example we taken 2 to be a multiple of n 1 = 25 up to a maximum of N = 250.
• Note thatn 2 is random and a function of S n 1
• To maintain type I error we reject when
Some Notation
• Let N denote maximum sample size to be considered • A level α test has the property that
Inefficiency of Adaptive Designs
Stopping Rules (Group-Sequential and Adaptive tests)
• Decisions to stop the study can be made after
• The sample space Z N is partitioned into a sequence of mutually exclusive and exhaustive rejection and acceptance regions
• A level α sequential test has the property that
Example using Adaptive Test
• Decisions for stopping can be made after n j = 25j observations j = 1, . . . , 10
• R 1 = S 25 > 13.84
• where 11.65, 13 .84], Γ 10 = [2.19, 5.49)
Operating Characteristics
• Sequential tests (including adaptive) allow possibility of stopping early and either rejecting or accepting null hypothesis
• The operating characteristics can be summarized by -Rejection spending function
• These are monotone functions in j for j = 1, . . . , K for all δ
Optimality
• If we have two competing level α tests for H 0 : δ ≤ 0 versus H A : δ > 0, with rejection-acceptance regions
then we say that "test" 1 is uniformly better than "test 2" if
Generalization of Neyman-Pearson Theorem
• Define the α and θ spending functions as
• For prespecified α and θ spending functions, define the sequential likelihood ratio test for testing the simple null hypothesis δ = 0 against the simple alternative δ = δ 1 as the test which rejects at the first time j when
and accepts at the first time j when
Theorem 1: The optimal sequential test for the simple null hypothesis
versus the simple alternative
with a specified α(θ)-spending function is the sequential likelihood ratio test
• By optimal, we mean that for any other sequential test with the same α and θ spending function, we have
• If we go back to our example of testing equality in the mean of normally distributed responses between two treatments, the sequential likelihood ratio test is equivalent to rejecting at the first j when
and accepting at the first j when
• The test above does not depend on the specific alternative δ 1 > 0, hence it is uniformly more powerful for δ > 0 than any other sequential test with the same α and θ spending function
• By reversing the role of rejection and acceptance we can also show that the above test also is uniformly better in accepting the null hypothesis
• Consequently, among all sequential tests with a prespecified α and θ spending function, the likelihood ratio sequential test defined above is uniformly best
Inferiority of the Adaptive Design
• Any level α adaptive test, no matter how complex, has an induced α and θ spending function as well as rejection and acceptance functions β(j, δ) and φ(j, δ) for j = 1, . . . , K and for all δ
• We can always construct a likelihood ratio sequential test with the same α and θ spending function as that for the adaptive design
• By the main theorem we know that the likelihood ratio sequential test must be uniformly better than the adaptive design
• Returning to our example of an adaptive design, the alpha-theta function is given by 
Conclusions
• Although on the surface adaptive designs have a great deal of appeal, after examining these designs more carefully we find that they are uniformly inferior to standard sequential tests
• Perhaps a better strategy would be for the statisticians and collaborators to choose a range of possible treatment differences that include -A larger treatment difference believed to be plausible δ init -A minimally acceptable treatment difference, perhaps corresponding to maximum sample size N
• Search for standard sequential designs with specified power to detect the minimally acceptable difference and have high probability of rejecting H 0 as early as possible for the plausible range of treatment differences
